Laura de-la-Puente-Ovejero

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsElectrochemical energy storage and conversionMedical molecular engineering of nucleic acids and proteinsEnergy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 06, 2026
RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1.

Laura de-la-Puente-Ovejero, Ana Fernández-Rodríguez, Sarah Francoz

|Sep 15, 2021
Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening.

Patricia Soblechero-Martín, Edurne Albiasu-Arteta, Aina Anton-Martinez

|May 17, 2021
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies.

Patricia Soblechero-Martín, Andrea López-Martínez, Laura de la Puente-Ovejero

|Sep 25, 2020
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.

Andrea López-Martínez, Patricia Soblechero-Martín, Laura de-la-Puente-Ovejero

Pageof 1